Fundraising FoxMed-Fine Capital
Venture capitalShanghai · Seed–Series A · 8 people tracked
Find your way into Med-Fine Capital
Each arrow is one introduction. Sign up to fill in the first one.
Ask Vikram Mohan to introduce you to Kosuke Ueda
You →Vikram · together at UTokyo Innovation Platform Co. Ltd. →Kosuke
Sign up to find every way you can get introduced to Med-Fine Capital
- Your email: who you already know at Med-Fine Capital, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Med-Fine Capital team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Med-Fine Capital invests in the pharmaceutical, healthcare, and life sciences sectors with an emphasis on discovering early-stage value and emerging opportunities. The firm targets novel drug development, biotechnology, medical devices, and cross-disciplinary innovation. Backed by a management team with international perspective, deep industry experience, and extensive sector resources, it manages several RMB- and USD-denominated funds. Its stated vision is to serve as a connecting bridge for global healthcare, and its mission is to leverage capital to drive innovation in the healthcare industry. The firm combines institutionalized management with systematic operations, aiming to become an open, platform-oriented, and internationally recognized specialist investment institution.
Source: firm website, verified Oct 1, 2026.
Team · 8 people
from curated & public directoriesWhat they invest in
from 2 of 15 portfolio companiesDeep Tech ×2Medical Devices ×2Biotech ×1Healthtech ×1
HQs:China×1
Investments · 15 tracked
founders shown can be your intro pathA biopharmaceutical company that develops antibody-based drugs using its own integrated antibody technology platforms, with a pipeline spanning a marketed product and multiple clinical and preclinical candidates.
BiotechDeep TechMedical Devices
MagAssist develops a multi-organ support platform for cardiac and critical care, starting from heart failure treatment.
Deep TechHealthtechMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
亦诺微凌科药业安锐生物安颂科技捍宇医疗水木医疗澎立生物礼邦医药艾科脉诚益生物赛赋医药赞荣医药达歌生物 (Degron Therapeutics)
Frequently asked questions
- How many investments has Med-Fine Capital made?
- Med-Fine Capital has 15 tracked investments.
- What stage does Med-Fine Capital invest at?
- Med-Fine Capital invests at the Seed, Series A stages.
- What sectors does Med-Fine Capital focus on?
- Med-Fine Capital focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Med-Fine Capital located?
- Med-Fine Capital is headquartered in Shanghai, CN.
- Does Med-Fine Capital lead rounds?
- Med-Fine Capital typically participates in rounds rather than leading them.
Similar investors
Future Positive Capital is a venture firm backing entrepreneurs building companies that address large-scale global challenges across health, sustainability and technology.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
NJF Capital is the venture investment arm of NJF Holdings, the private investment group founded by Nicole Junkermann. It backs transformative entrepreneurs building industry-defining technologies with global scale potential.
CABHI (Centre for Aging + Brain Health Innovation) is a pan-Canadian organization that funds and supports researchers, innovators, and startups working on brain health and aging solutions, and helps healthcare and community organizations adopt them.